Physiomics plc announced the hiring of a new member of its senior management team. Effective immediate, Dr. Peter Sargent will be joining the Company as Chief Operating Officer. Prior to joining us, Dr. Sargent held a senior management role at global consultancy business Syneos Health Inc. (NASDAQ: SYNH), leading large teams of professionals and servicing a variety of clients in the biopharmaceuticals space.

Among his earlier roles, Dr. Sargent has also been Head of Business Development for the UK's National Institute for Health and Care Research (NIHR), leading a team supporting global life science businesses access to funding and research infrastructure in the UK. The COO role will help to formulate the Company's overall business strategy and play a pivotal role in driving its execution. The initial focus will be to strengthen the operational performance of the Company and in particular drive the key priorities announced during the Company's recent placing, namely: further expansion and diversification of its client base; expansion of its consulting business into the adjacent area of pharmaceutical biostatistics services; and exploration of opportunities around its personalised oncology software offering.

Dr. Sargent will join as a key member of the Company's senior leadership team (but not as a board director) and will report directly to Dr. Jim Millen. The hiring of Dr. Sargent forms part of a strategy to revert to a more traditional board structure where the roles of Executive Chairman and CEO are separated.